https://www.sciencedaily.com/releases/2005/01/050104112710.htm
Triple-drug antiretroviral regimens that are widely used in the United States and Europe against one HIV-1 subtype appear to be effective in South African...
drug therapyhiv subtypetripleafricansciencedaily
https://www.uclahealth.org/news/release/ucla-receives-nearly-14-million-nih-investigate-gene-therapy
UCLA researchers and colleagues have received a $13.65 million grant from the National Institutes of Health to investigate and further develop an immunotherapy...
uclareceivesnearlymillionnih
https://ourworldindata.org/grapher/antiretroviral-therapy-coverage-among-people-living-with-hiv?tab=chart&country=FRA
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.
people with hivantiretroviral therapysharereceive
https://www.jnj.com/media-center/press-releases/u-s-fda-approves-streamlined-process-for-initiating-hiv-therapy-with-cabenuva-cabotegravir-and-rilpivirine-the-first-and-only-complete-long-acting-injectable-hiv-treatment
Adults living with HIV now have an option to start injectable regimen without the need for an oral lead-in period first
u shiv therapyfdastreamlinedprocess
https://www.cochrane.org/de/evidence/CD007331_shifting-hiv-care-doctors-non-doctors-improve-access-therapy-people-living-hiv
shiftinghivcaredoctorsnon
https://www.news-medical.net/news/20260114/Immune-dysfunction-persists-after-combined-TB-and-HIV-therapy.aspx
The immune system remains seriously out-of-whack – in an inflammatory state of overactivation and impaired functionality – following the international gold...
immune dysfunctionhiv therapypersistscombinedtb
https://www.benzinga.com/general/biotech/21/11/24270813/gilead-merck-stop-enrollment-in-mid-stage-hiv-combination-therapy-trial
Gilead Sciences Inc (NASDAQ: GILD) and Merck & Co Inc (NYSE: MRK) have
combination therapygileadmerckstopenrollment